Tang H, Zhang B, Lu Y, Donahoo WT, et al. Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials. Diabetes Obes Metab 2025;27:1444-1455.
PMID: 39723481